Intracranial complete response for non‐small‐cell lung cancer patient with negative PD‐L1 expression of the lung using nivolumab

BACKGROUND: Nivolumab has shown promising results against non‐small‐cell lung cancer (NSCLC). However, its efficacy to treat central nervous system (CNS) metastases, specifically among programmed cell death 1 ligand 1 (PD‐L1)‐negative patients, remains unclear. CASE: A 66‐year‐old woman was diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitadai, Rui, Zenke, Yoshitaka, Hishima, Tsunekazu, Hosomi, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842707/
https://www.ncbi.nlm.nih.gov/pubmed/34042323
http://dx.doi.org/10.1002/cnr2.1460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842707/
https://www.ncbi.nlm.nih.gov/pubmed/34042323
http://dx.doi.org/10.1002/cnr2.1460

Ejemplares similares